No cutaneous histamine release with buprenorphine?

Area of Science:

• Pharmacology
• Dermatology
• Clinical Research

Background:

• Opioid analgesics, or narcotics, are known to induce histamine release.
• Histamine release can cause systemic and cutaneous reactions.
• The histamine-releasing potential of buprenorphine, an opioid, remains uncharacterized.

Purpose of the Study:

• To investigate whether buprenorphine causes histamine release.
• To assess the cutaneous effects of buprenorphine administration in human subjects.

Main Methods:

• Intradermal injections of buprenorphine at various dilutions (1:10,000 to 1:10) were administered to 11 healthy adults.
• Control substances included 0.9% saline and histamine (10(-3) mol/l).
• Dermal reactions were evaluated at 15 and 30 minutes post-injection.

Main Results:

• No volunteer exhibited any cutaneous reactions indicative of histamine release upon administration of buprenorphine.
• Saline controls showed no reactions, while histamine controls elicited expected reactions.
• Buprenorphine demonstrated an absence of histamine-releasing activity in this study.

Conclusions:

• Buprenorphine does not appear to possess histamine-releasing properties.
• The lack of histamine release may be attributed to buprenorphine's chemical structure or insufficient local concentration at mast cell membranes.
• Further research may explore the underlying mechanisms for buprenorphine's non-histamine-releasing profile.